Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy) | MicrobiomeTrials← Back to trialsNCT07221331
Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy)
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-11-19Est. Completion: 2026-09-30
Enrollment target: 200 participants Locations- Research Site, Al Mansurah, Egypt
- Research Site, Alexandria, Egypt
- Research Site, Aswān, Egypt
- Research Site, Asyut, Egypt
- Research Site, Cairo, Egypt
- Research Site, Cairo, Egypt
- Research Site, Sohag, Egypt
- Research Site, Tanta, Egypt
- Research Site, Zagazig, Egypt
Other microbiome trials you might be interested in
Low Grade AstrocytomaLow Grade GliomaMetastatic Low Grade AstrocytomaMetastatic Low Grade GliomaWHO Grade 1 GliomaWHO Grade 2 Glioma
This phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincr…
Birmingham, United StatesEst. completion Dec 31, 2030
Low Grade Glioma (LGG) of Brain With BRAF AberrationHigh Grade Glioma (HGG) of the Brain With BRAF Aberration
Low Grade Glioma of Brain With Neurofibromatosis Type 1
This phase I/II trial is designed to study the side effects, best dose and efficacy of adding hydroxychloroquine to dabr…
Phoenix, United StatesEst. completion Oct 1, 2026